October 2, 2018 by Dale Yuzuki
The first cell-free Pillar Biosciences publication answers several questions about reported discordance between genotyping matched tumor tissue and circulating tumor DNA collected and processed under different conditions. Last year two [more]
September 24, 2018 by Dale Yuzuki
Being unaware of oncology precision medicine or being oversold on oncology precision medicine are both undesirable outcomes There are two opposing forces at work in genetic and genomic testing for [more]
September 11, 2018 by Dale Yuzuki
The annual Advances in Genome Biology and Technology – Precision Health 2018 meeting was held in La Jolla California on Sept 6 – 8, 2018. Pillar Biosciences presented a poster called [more]
August 27, 2018 by Dale Yuzuki
At this year’s Next Generation Diagnostics Conference held in Washington DC, Pillar Biosciences presented a poster entitled “Development and Evaluation of a Lung Cancer Fusion RNA Panel” with first author [more]
August 7, 2018 by Dale Yuzuki
Choosing between multiplex PCR enrichment methods? A few reasons to look at alternatives to AmpliSeq. If you turn back the clock to late 2011, it was an exciting time for [more]
July 23, 2018 by Dale Yuzuki
At 18% growth compounded annually, you’ll need to double your productivity every four years Market research is a strange animal. This industry depends upon the opinion of those they follow [more]
June 21, 2018 by Dale Yuzuki
Overlapping multiplex PCR gives single-well simplicity and outstanding data quality Introduction There is an ongoing need for the clinical laboratory operations to be made more streamlined, simplified and economical. With [more]
May 24, 2018 by Dale Yuzuki
The universe of cancer research is so large and so wide-ranging that attending a conference like the recent American Association for Cancer Research (#AACR18) in Chicago you may discover rising [more]
April 24, 2018 by Dale Yuzuki
American Association for Cancer Research 2018 Lung & Colon Cancer Panel in a CRC Cohort Poster Interview with Dr. Jianfeng Xiao At the recent American Association for Cancer Research (#AACR18), [more]
April 11, 2018 by Dale Yuzuki
At the recent Association for Molecular Pathology conference in Salt Lake City, Utah, we had the opportunity to ask Dr. Gang Song, Chief Executive Officer of Pillar Biosciences to talk [more]